Cargando…
Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists
‘Biased’ ligands of G protein-coupled receptors (GPCRs) represent a type of promising analgesic with reduced on-target side effects. PZM21, a potent μ-opioid-receptor (μOR)-biased agonist with a new chemical scaffold compared to classic opioids, has been identified as a therapeutic lead molecule for...
Autores principales: | Ma, Mengjun, Sun, Jialin, Li, Menghua, Yu, Zixing, Cheng, Jingchao, Zhong, Bohua, Shi, Weiguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359544/ https://www.ncbi.nlm.nih.gov/pubmed/30641969 http://dx.doi.org/10.3390/molecules24020259 |
Ejemplares similares
-
Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist
por: Doi, Seira, et al.
Publicado: (2016) -
Desmetramadol Is Identified as a G-Protein Biased µ Opioid Receptor Agonist
por: Zebala, John A., et al.
Publicado: (2020) -
Structure‐Based Evolution of G Protein‐Biased μ‐Opioid Receptor Agonists
por: Wang, Haoqing, et al.
Publicado: (2022) -
A Facile Synthesis for Novel Loperamide Analogs as Potential μ Opioid Receptor Agonists
por: Bao, Xiaofeng, et al.
Publicado: (2012) -
Influence of G protein-biased agonists of μ-opioid receptor on addiction-related behaviors
por: Kudla, Lucja, et al.
Publicado: (2021)